MoneyWorks4Me

Aurobindo Pharma receives USFDA tentative approval for Sildenafil Citrate Tablets

21 Jul 2015 Evaluate

Aurobindo Pharma has received tentative approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Citrate Tablets 25 mg, 50 mg and 100 mg. Viagra is the brand name for Sildenafil Citrate, and is used for treating erectile dysfunction and pulmonary arterial hypertension.

Aurobindo is a 'Vertically Integrated' pharmaceutical companies in India, It has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..